Shares of Rexahn Pharmaceuticals (RNN) fall 14% premarket on top of Tuesday's 27% decline.
The company is set to sell $20M worth of units in a registered direct offering.
Each unit consists of one share of common and a five-year warrant to purchase 0.25 of a share.
The price per unit is $1.05. (PR)